|
|||||
|
|
Impact of brodalumab treatment on psoriasis symptoms and health‐related quality of life: use of a novel patient‐reported outcome measure,the Psoriasis Symptom Inventory |
|
| Authors: | K.B. Gordon A.B. Kimball D. Chau H.N. Viswanathan J. Li D.A. Revicki G. Kricorian B.G. Ortmeier |
| Affiliation: | 1. Department of Dermatology, Northwestern University, Feinberg School of Medicine, , Chicago, IL, 60611 U.S.A;2. Massachusetts General Hospital, Harvard Medical School, , Boston, MA, U.S.A;3. Amgen Inc., , Thousand Oaks, CA, U.S.A;4. Outcomes Research, UnitedBioSource Corporation, , Bethesda, MD, U.S.A |
| Abstract: | |
| Keywords: | |